Lapidus Stanley
SEC CIK 1678195 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LUCD | Lucid Diagnostics Inc. | Dir | 337.4K | — | $112.5K | 6 | 2022-09-20 | 2026-02-20 |
Most active insiders at LUCD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Matheis Dennis | Dir | $245.3K | — |
| 2 | Gordon Michael Adam | GC, Sec | — | — |
| 3 | O'Neil Shaun | Pres, COO | — | — |
| 4 | White Debra | Dir | — | — |
| 5 | Lapidus Stanley | Dir | — | — |
| 6 | Cox James L | Dir | — | — |
| 7 | Sparks Ronald M | Dir | — | — |
| 8 | Aklog Lishan | CEO, Dir | — | — |
| 9 | SOKOLOV JACQUE J | Dir | — | — |
| 10 | MCGRATH DENNIS M | CFO | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-24 | 2026-02-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | A - Grant | $0.00 | +123.0K | 337.4K | +57% | $0 | |
| 2025-02-21 | 2025-02-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | A - Grant | $0.00 | +112.8K | 214.4K | +111% | $0 | |
| MA | 2023-09-27 | 2023-09-20+ | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 132.1K | -3% | -$5,675 |
| M | 2023-09-27 | 2023-09-25+ | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -29.9K | 101.6K | -23% | -$43.4K |
| M | 2023-09-22 | 2023-09-20+ | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.45 | -3,917 | 131.5K | -3% | -$5,675 |
| M | 2022-09-22 | 2022-09-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Dir | S - Sale | $1.71 | -33.9K | 135.5K | -20% | -$57.7K |
Purchase Sale Sale after option exercise All abbreviations